These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2523644)

  • 41. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris.
    Rüegg PC; Nelson DJ
    Am J Med; 1989 Apr; 86(4A):70-4. PubMed ID: 2565689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
    Persson B; Wysocki M; Andersson OK
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):22-4. PubMed ID: 2475710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A; Cristal N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
    Jespersen LT; Krusell LR; Sihm I; Pedersen OL
    Am J Med; 1989 Apr; 86(4A):57-9. PubMed ID: 2523656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients.
    Batlouni M; Armaganijan D; Ghorayeb N; Magliano MF
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
    Hermans L; Bogaert M; Degaute JP; Rorive G; Six R; Bara L; Lanssiers P; De Keyser P; Westelinck KJ
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S38-45. PubMed ID: 1376833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
    Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF; Waeber B
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isradipine in the treatment of mild to moderate essential hypertension.
    Leary WP; Maharaj B; Van der Byl K
    S Afr Med J; 1991 Oct; 80(7):322-3. PubMed ID: 1833834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
    Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative evaluation of the antihypertensive efficacy of once-daily sustained-release isradipine and lacidipine using 24-hour ambulatory blood-pressure monitoring.
    Galderisi M; Petrocelli A; Garofalo M; Celentano A; Alfieri A; de Divitiis O
    J Int Med Res; 1995; 23(4):234-43. PubMed ID: 7589766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antihypertensive action of isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Farragi D
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
    Furberg CD; Byington RP; Borhani NA
    Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of the international literature on isradipine in hypertension (Lomir/Dynacirc).
    Soland FX
    Cor Vasa; 1990; 32(2 Suppl 1):61-72. PubMed ID: 2143461
    [No Abstract]   [Full Text] [Related]  

  • 58. [Isradipine, a calcium antagonist in hypertension].
    Christensen HR; Graudal N
    Ugeskr Laeger; 1990 Aug; 152(34):2448-50. PubMed ID: 2144928
    [No Abstract]   [Full Text] [Related]  

  • 59. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
    Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
    J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.